Please see the below resources for further information.
- Guidelines on oral anticoagulation with warfarin, 4th edition
- Peri-operative management of anticoagulation and antiplatelet therapy
- Patient self-testing and self-management of vitamin K antagonists
- Template service audit form – uses BSH/NPSA safety indicators
- Information for community pharmacists, GPs and social care providers
- Poster for dental practices on how to manage patients who are taking warfarin and undergoing dental treatment
- British Society of Haemotology Standards for anticoagulants
- Risk assessment reports
- Patient information in English and other languages
The National Institute for Health and Care Excellence (NICE) has guidelines on the management of:
- Atrial fibrillation
- Venous thromboembolism
- Choice of Point of Care device for patients taking vitamin K antagonists who wish to self-test
The European Cardiology Society has a useful guideline on the management of Atrial Fibrillation
The European Heart Rhythm Association has published excellent practical guidance on the safe management and monitoring of patients taking DOACs (direct oral anticoagulants)
The British Society of Gastroenterology has published guidance on the management of patients on warfarin, DOACs and antiplatelet medicines who are undergoing endoscopic procedures.
Further information on the Roche CoaguChek® anticoagulation point–of –care devices
- For healthcare professionals – the CoaguChek® XS plus
- For self-testing patients – the CoaguChek® XS or the CoaguChek® INRange
NEQAS – the UK National External Quality Assessment Service – provides external quality control testing for all anticoagulation point-of-care devices, including the CoaguChek®.
INRstar is a computer decision support system (CDSS) which can assist with anticoagulation dosing, recall and follow up.
Patients who are self-testing can use the ENGAGE app to upload their INR directly from their CoaguChek® INRange device to their INRstar patient record. All the patient needs to do this is an internet-enabled device and an internet connection.
The ENGAGE app also helps patients adhere to their anticoagulant treatment by giving them daily dosing reminders and next test date reminders.